Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

19.7%

28 terminated/withdrawn out of 142 trials

Success Rate

72.5%

-14.0% vs industry average

Late-Stage Pipeline

20%

28 trials in Phase 3/4

Results Transparency

72%

53 of 74 completed trials have results

Key Signals

17 recruiting53 with results21 terminated7 withdrawn

Enrollment Performance

Analytics

N/A

82(68.9%)

Phase 4

18(15.1%)

Phase 3

10(8.4%)

Phase 1

6(5.0%)

Phase 2

2(1.7%)

Early Phase 1

1(0.8%)

119Total

N/A(82)

Phase 4(18)

Phase 3(10)

Phase 1(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (142)

Showing 20 of 142 trials

NCT06168942Not ApplicableSuspended

A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

Role: lead

NCT07227532Not ApplicableRecruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Role: lead

NCT05971693Not ApplicableCompleted

A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator

Role: lead

NCT07845682Not ApplicableNot Yet Recruiting

A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation

Role: lead

NCT05565599Not ApplicableActive Not Recruiting

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Role: lead

NCT03963349Active Not Recruiting

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study

Role: lead

NCT07116525Not ApplicableRecruiting

A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

Role: lead

NCT07727057Not ApplicableRecruiting

A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treatment of Ventricular Arrhythmias

Role: lead

NCT07527299Not ApplicableRecruiting

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

Role: lead

NCT07428564Not ApplicableRecruiting

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE PRO Software in Participants With PsAF

Role: lead

NCT06455098Not ApplicableActive Not Recruiting

A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

Role: lead

NCT04750798Recruiting

An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias

Role: lead

NCT07429214Not ApplicableRecruiting

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF

Role: lead

NCT04088071Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Role: collaborator

NCT07523750Not ApplicableRecruiting

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

Role: lead

NCT07788989Not ApplicableNot Yet Recruiting

A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter

Role: lead

NCT07236619Not ApplicableActive Not Recruiting

Durability of Pulmonary Vein Isolation Using a Variable-Loop Biphasic Pulsed Field Ablation Catheter in Patients With Paroxysmal Atrial Fibrillation

Role: collaborator

NCT02565069Not ApplicableCompleted

Identification for the Treatment of Complex Arrhythmias

Role: lead

NCT05685134Not ApplicableCompleted

Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome